| Primary |
| Anaesthesia |
25.9% |
| Sedation |
14.9% |
| Induction Of Anaesthesia |
13.9% |
| General Anaesthesia |
10.4% |
| Sedative Therapy |
6.0% |
| Maintenance Of Anaesthesia |
4.8% |
| Product Used For Unknown Indication |
4.4% |
| Status Epilepticus |
2.9% |
| Anaesthesia Procedure |
2.4% |
| Colonoscopy |
2.1% |
| Induction And Maintenance Of Anaesthesia |
1.6% |
| Endoscopy |
1.5% |
| Abortion Induced |
1.5% |
| Analgesic Therapy |
1.3% |
| Convulsion |
1.2% |
| Premedication |
1.2% |
| Surgery |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Pain |
1.0% |
| Intracranial Pressure Increased |
0.9% |
|
| Pyrexia |
13.7% |
| Propofol Infusion Syndrome |
11.4% |
| Respiratory Depression |
7.0% |
| Rhabdomyolysis |
6.3% |
| Wrong Technique In Drug Usage Process |
6.0% |
| Transmission Of An Infectious Agent Via A Medicinal Product |
5.5% |
| Ventricular Tachycardia |
4.6% |
| Vomiting |
4.6% |
| Respiratory Arrest |
4.4% |
| Tremor |
3.9% |
| Anaphylactic Shock |
3.8% |
| Hepatitis C |
3.7% |
| Renal Failure Acute |
3.7% |
| Tachycardia |
3.7% |
| Toxicity To Various Agents |
3.7% |
| Sepsis |
3.3% |
| Cardiac Arrest |
2.8% |
| Hypotension |
2.7% |
| Oxygen Saturation Decreased |
2.7% |
| Product Contamination |
2.7% |
|
| Secondary |
| Anaesthesia |
20.8% |
| Drug Use For Unknown Indication |
14.1% |
| Product Used For Unknown Indication |
13.8% |
| General Anaesthesia |
9.5% |
| Induction Of Anaesthesia |
9.0% |
| Sedation |
7.5% |
| Maintenance Of Anaesthesia |
5.1% |
| Premedication |
2.7% |
| Analgesic Therapy |
2.2% |
| Hypertension |
2.2% |
| Pain |
2.1% |
| Prophylaxis |
1.8% |
| Status Epilepticus |
1.7% |
| Anaesthesia Procedure |
1.6% |
| Sedative Therapy |
1.2% |
| Surgery |
1.0% |
| Analgesia |
1.0% |
| Non-hodgkin's Lymphoma |
0.9% |
| Convulsion |
0.9% |
| Muscle Relaxant Therapy |
0.9% |
|
| Rhabdomyolysis |
12.1% |
| Renal Failure Acute |
8.9% |
| Propofol Infusion Syndrome |
8.0% |
| Tachycardia |
6.8% |
| Anaphylactic Reaction |
6.7% |
| Pyrexia |
6.2% |
| Hypotension |
5.7% |
| Toxic Epidermal Necrolysis |
5.2% |
| Ventricular Tachycardia |
5.2% |
| Cardiac Arrest |
4.2% |
| Anaphylactic Shock |
4.1% |
| Ventricular Fibrillation |
4.1% |
| Vomiting |
3.9% |
| Urticaria |
3.6% |
| Cognitive Disorder |
3.4% |
| Drug Interaction |
2.5% |
| Renal Failure |
2.5% |
| Respiratory Arrest |
2.4% |
| Respiratory Failure |
2.4% |
| Sinus Tachycardia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.5% |
| Drug Use For Unknown Indication |
17.2% |
| Anaesthesia |
8.2% |
| Induction Of Anaesthesia |
4.6% |
| Prophylaxis |
4.5% |
| General Anaesthesia |
3.6% |
| Sedation |
3.0% |
| Maintenance Of Anaesthesia |
2.8% |
| Pain |
2.5% |
| Hypertension |
2.5% |
| Surgery |
2.1% |
| Coronary Artery Bypass |
1.8% |
| Analgesic Therapy |
1.5% |
| Premedication |
1.5% |
| Non-small Cell Lung Cancer |
1.1% |
| Sepsis |
1.1% |
| Thrombosis Prophylaxis |
0.9% |
| Infection Prophylaxis |
0.9% |
| Depression |
0.8% |
| Medical Diet |
0.8% |
|
| Vomiting |
8.6% |
| Tachycardia |
7.1% |
| Injury |
6.7% |
| Pain |
6.6% |
| Serotonin Syndrome |
6.6% |
| Ventricular Tachycardia |
5.9% |
| Unresponsive To Stimuli |
5.4% |
| Sepsis |
5.2% |
| Hypotension |
4.8% |
| Renal Failure |
4.5% |
| Rhabdomyolysis |
4.3% |
| Unevaluable Event |
4.2% |
| Ventricular Fibrillation |
4.1% |
| Loss Of Consciousness |
4.0% |
| Fear |
3.9% |
| Respiratory Failure |
3.9% |
| Renal Failure Acute |
3.8% |
| Thrombocytopenia |
3.8% |
| Pulmonary Embolism |
3.4% |
| Anhedonia |
3.3% |
|
| Interacting |
| General Anaesthesia |
21.8% |
| Product Used For Unknown Indication |
15.2% |
| Induction Of Anaesthesia |
8.9% |
| Maintenance Of Anaesthesia |
7.8% |
| Drug Use For Unknown Indication |
7.4% |
| Osteotomy |
7.1% |
| Musculoskeletal Pain |
5.5% |
| Anaesthesia |
5.0% |
| Anaesthesia Procedure |
4.5% |
| Neuralgia |
3.0% |
| Pain |
2.6% |
| Craniotomy |
2.4% |
| Varicose Vein Operation |
1.8% |
| Abdominal Pain |
1.4% |
| Restlessness |
1.4% |
| Restless Legs Syndrome |
1.1% |
| Spinal Anaesthesia |
0.9% |
| Sedation |
0.9% |
| Brain Operation |
0.8% |
| Endotracheal Intubation |
0.8% |
|
| Sinus Tachycardia |
17.5% |
| Drug Interaction |
16.9% |
| Myotonia |
13.6% |
| Potentiating Drug Interaction |
9.6% |
| Hypotension |
6.8% |
| Myoclonus |
6.8% |
| Atrioventricular Dissociation |
3.4% |
| Cardiac Arrest |
2.3% |
| Disorientation |
2.3% |
| Fall |
2.3% |
| Infectious Peritonitis |
2.3% |
| Opisthotonus |
2.3% |
| Peritonitis |
2.3% |
| Pulmonary Embolism |
2.3% |
| Ventricular Fibrillation |
2.3% |
| No Adverse Event |
1.7% |
| Respiratory Failure |
1.7% |
| Tachycardia |
1.7% |
| Extrasystoles |
1.1% |
| Incorrect Dose Administered |
1.1% |
|
